These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21707506)

  • 21. Protein-tyrosine phosphatases and cancer.
    Ostman A; Hellberg C; Böhmer FD
    Nat Rev Cancer; 2006 Apr; 6(4):307-20. PubMed ID: 16557282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Dominant-Negative/Substrate Trapping PTP Mutations to Search for PTP Interactors/Substrates.
    Radha V
    Methods Mol Biol; 2016; 1447():243-65. PubMed ID: 27514810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
    He R; Zeng LF; He Y; Zhang S; Zhang ZY
    FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
    Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
    BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.
    Wiener JR; Kassim SK; Yu Y; Mills GB; Bast RC
    Gynecol Oncol; 1996 May; 61(2):233-40. PubMed ID: 8626139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic alterations of protein tyrosine phosphatases in human cancers.
    Zhao S; Sedwick D; Wang Z
    Oncogene; 2015 Jul; 34(30):3885-94. PubMed ID: 25263441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases.
    Elson A
    Int J Biochem Cell Biol; 2018 Mar; 96():135-147. PubMed ID: 28941747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal-based inhibitors of protein tyrosine phosphatases.
    Lu L; Zhu M
    Anticancer Agents Med Chem; 2011 Jan; 11(1):164-71. PubMed ID: 21269257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein tyrosine phosphatase inhibition by metals and metal complexes.
    Lu L; Zhu M
    Antioxid Redox Signal; 2014 May; 20(14):2210-24. PubMed ID: 24382261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inside the human cancer tyrosine phosphatome.
    Julien SG; Dubé N; Hardy S; Tremblay ML
    Nat Rev Cancer; 2011 Jan; 11(1):35-49. PubMed ID: 21179176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-specificity phosphatases as targets for antineoplastic agents.
    Lyon MA; Ducruet AP; Wipf P; Lazo JS
    Nat Rev Drug Discov; 2002 Dec; 1(12):961-76. PubMed ID: 12461518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug discovery and protein tyrosine phosphatases.
    Blaskovich MA
    Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity-based high-throughput determination of PTPs substrate specificity using a phosphopeptide microarray.
    Gao L; Sun H; Yao SQ
    Biopolymers; 2010; 94(6):810-9. PubMed ID: 20725946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
    Zhang ZY
    Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein tyrosine phosphatase 1B in hematopoiesis.
    Heinonen KM; Tremblay ML
    Cell Cycle; 2006 May; 5(10):1053-6. PubMed ID: 16687929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).
    Park JE; Park BC; Song M; Park SG; Lee DH; Park SY; Kim JH; Cho S
    Biochem Biophys Res Commun; 2009 Oct; 387(4):795-9. PubMed ID: 19646420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.